Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial
| Autor: | Hansson, Johan, Aamdal, Steinar, Bastholt, Lars, Brandberg, Yvonne, Hernberg, Micaela, Nilsson, Bo, Stierner, Ulrika, von der Maase, Hans |
|---|---|
| Zdroj: | In Lancet Oncology 2011 12(2):144-152 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|